✦ LIBER ✦

99 Efficacy and toxicity profile of gemcitabine in previously treated patients with non-small cell lung cancer (NSCLC)

✍ Scribed by Guerra, J.A.; Lianes, P.; Paz-Ares, L.; Castellano, D.; Gómez-Martín, C.; Cortés-Funes, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of gemcitabine in no

✍ Abratt, R; Bezwoda, W; Falkson, G; Goedhals, L; Hacking, D; Rugg, T 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Toxicity of single gemcitabine (GEM) in

✍ Mali, P; Liippo, K; Nikkanen, T.A.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Phase II study of gemcitabine + Vindesin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 150 KB

31 Differential efficacy and toxicity pr

✍ Nguyen, B.; Sandler, A.; Crino, L.; Abratt, R.P.; Steward, W.; Green, M.R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase II trial of gemcitabine and irinot

✍ Fumiyoshi Ohyanagi; Atsushi Horiike; Yoshio Okano; Yukitoshi Satoh; Sakae Okumur 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 298 KB

Clinical efficacy of erlotinib in patien

✍ Songwen ZHOU; Shengxiang REN; Lianghua YAN; Ling ZHANG; Liang TANG; Jie ZHANG; C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB